Patent ID: 6255296
Filing Date: 2001-07-03
Classification: A61K,Y10S

Abstract:
A method for treating a patient susceptible to or suffering from at least one of atherosclerosis, arteriosclerosis, congestive heart failure, stroke, arterial dysfunction, re-stenosis, hypertension, smooth muscle cell hydrophy, thrombogenicity, clotting disorders, platelet disorders, myocardial infarction, cerebrovascular ischemia, or peripheral vascular ischemia, said method comprising orally administering to said patient a therapeutically effective amount of a first substance selected from the group consisting of heparin, heparin sulfate, taprostene, prostacyclin, and physiologically acceptable salts thereof, and a therapeutically effective amount of a second substance selected from the group consisting of arginine, arginine sulfate, and physiologically acceptable salts thereof.